-
-
-
-
-
-
-
Increasing unusual put option volume: SLS WMB NUAI RARE PPLT DBRG BTG HWM TECL UBS HYMC
-
-
-
-
-
-
-
SELLAS (SLS) appoints Linghua Wang to scientific advisory board
-
-
-
-
-
-
-
SELLAS Life Sciences (SLS) Announces Positive Overall Survival in Cohort 3 from the Ongoing Phase 2 Trial of SLS009 in r/r AML
-
-
-
-
-
-
-
SELLAS Life Sciences (SLS) Announces Positive Data from Preclinical Studies Indicating ASXL1 Mutations as Predictor of Response to SLS009 in Solid Cancers
-
-
-
-
-
-
-
SELLAS (SLS) Receives European Medicines Agency Orphan Drug Designation for SLS009 for the Treatment of Acute Myeloid Leukemia
-
-
-
456,272 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

